DiaSorin SpA (DIAm)

98.77
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    97.72/99.68
  • Day's Range:
    98.66 - 99.02
Earnings results expected today

Diasorin will announce its quarterly financial results today. Traders should take this into account as the share price often fluctuates around this time period.

DIAm Overview

Prev. Close
98.98
Day's Range
98.66-99.02
Revenue
1.29B
Open
98.98
52 wk Range
96.34-143.55
EPS
3.74
Volume
0
Market Cap
5.22B
Dividend (Yield)
1.10
(1.05%)
Average Vol. (3m)
1,218
P/E Ratio
26.39
Beta
0.134
1-Year Change
-18.05%
Shares Outstanding
53,517,885
Next Earnings Date
May 30, 2023
What is your sentiment on Diasorin?
or
Market is currently closed. Voting is open during market hours.

DiaSorin SpA Company Profile

DiaSorin SpA Company Profile

Employees
3365
Market
Italy
  • Type:Equity
  • Market:Italy
  • ISIN:IT0003492391

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Read More

Analyst Price Target

Average108.74 (+11.46% Upside)
High130.00
Low86.00
Price97.56
No. of Analysts12
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellSellStrong SellStrong Sell
Technical IndicatorsSellStrong BuyStrong SellStrong SellStrong Sell
SummaryStrong SellNeutralStrong SellStrong SellStrong Sell
  • E comunwue oggi incremento . Bilanci dal 2020 raddoppiati.
    0
    • Che successe, mentre il resto sale?
      0
      • superata la curva alta di Bollinger,  punta a 160 ?
        0
      • Tobias Raederwell said! It did it now
        0
    • Overrated company, in my opinion you can sell Short Diasorin capitalization 11 billion euros Profits 175 million euros Turnover 800 million ISIN IT0003492391 diasorin
      7
      • short!!
        7
        • alla faccia del fattoquotidiano che oggi ha provato a dare un'altra spallata a questo gioiello... Coronavirus: da Fda via libera a test sierologico DiaSorin L'autorizzazione per analisi validata al San Matteo di Pavia (ANSA) - ROMA, 25 APR - DiaSorin annuncia di aver ricevuto l'Emergency Use Authorization (EUA) dalla Food and Drug Administration americana per il test LIAISON  SARS-CoV-2 S1/S2 IgG. Si tratta del nuovo test sierologico validato presso il Policlinico San Matteo a Pavia, uno dei centri di riferimento nazionali per la pandemia da COVID-19.
          3
          • DIASORIN COVID fast test has been approved by FDA
            0
            • nice news, not sure why is going down anyway
              0
            • When??????
              0
          • USA: Dow e NASDAQ han chiuso a +10%. Lunedì si parte da 120.10€. Buon weekend
            1
            • E invece... 109.90€ :D
              0
          • DiaSorin’s test could be ready within six weeks for consideration by the U.S. Food and Drug Administration, and the QIAGEN test could be ready within 12 weeks for FDA consideration, according to HHS.
            0
            • They just announced a fast test for COVID-19, 60 minutes against some hours
              0
              • 150€ during this year ?
                1